Major Shareholder Files Intent to Sell $4.95M in Sensei Biotherapeutics Stock
SNSE has more than doubled off its 52-week low of $5.25 on light trading volume (0.1× avg).
Summary
A 10% owner, Cambrian BioPharma Inc, has filed a Form 144 indicating intent to sell 155,142 shares of Sensei Biotherapeutics common stock, valued at approximately $4.95 million, amidst ongoing corporate restructuring.
Key Events · Ownership and Investor Activity · SNSE
-
Major Shareholder Intent to Sell
Cambrian BioPharma Inc, identified as a 10% stockholder, filed a Form 144 to sell 155,142 shares of common stock.
-
Significant Transaction Value
The proposed sale is valued at approximately $4.95 million, representing over 13% of the company's current market capitalization.
-
Context of Corporate Restructuring
This intent to sell occurs shortly after an S-3 registration for the resale of up to 24.87 million shares and amidst recent proxy filings detailing a 'massive recapitalization' and potential reverse stock split.
Analysis · SNSE · Life Sciences
Cambrian BioPharma Inc, a 10% stockholder, has filed a Form 144 indicating intent to sell 155,142 shares of Sensei Biotherapeutics common stock, valued at approximately $4.95 million. This proposed sale represents a significant portion of the company's market capitalization and suggests a substantial reduction in the major shareholder's stake. The timing is notable as it follows closely on the heels of an S-3 registration for the resale of up to 24.87 million shares and ongoing efforts for a 'massive recapitalization' and potential reverse stock split, adding to potential market overhang and dilution concerns.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SNSE was trading at $27.66 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $37.1M. The 52-week trading range was $5.25 to $36.76. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.